HomeComparePLXP vs PFE

PLXP vs PFE: Dividend Comparison 2026

PLXP yields 2298.85% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLXP wins by $36577739038.80M in total portfolio value
10 years
PLXP
PLXP
● Live price
2298.85%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36577739038.85M
Annual income
$33,694,466,973,692,370.00
Full PLXP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — PLXP vs PFE

📍 PLXP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLXPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLXP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLXP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLXP
Annual income on $10K today (after 15% tax)
$195,402.30/yr
After 10yr DRIP, annual income (after tax)
$28,640,296,927,638,510.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PLXP beats the other by $28,640,296,927,616,190.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLXP + PFE for your $10,000?

PLXP: 50%PFE: 50%
100% PFE50/50100% PLXP
Portfolio after 10yr
$18288869519.45M
Annual income
$16,847,233,486,859,314.00/yr
Blended yield
92.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PLXP
Analyst Ratings
2
Buy
3
Hold
Consensus: Hold
Altman Z
-10.3
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLXP buys
0
PFE buys
0
No recent congressional trades found for PLXP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLXPPFE
Forward yield2298.85%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$36577739038.85M$49.6K
Annual income after 10y$33,694,466,973,692,370.00$26,258.71
Total dividends collected$36375156338.99M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: PLXP vs PFE ($10,000, DRIP)

YearPLXP PortfolioPLXP Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$240,585$229,885.06$9,153$693.39+$231.4KPLXP
2$5,426,296$5,168,870.07$8,593$849.25+$5.42MPLXP
3$114,761,014$108,954,877.01$8,336$1,066.78+$114.75MPLXP
4$2,276,338,467$2,153,544,182.26$8,437$1,384.80+$2276.33MPLXP
5$42,357,698,654$39,922,016,494.37$9,013$1,875.40+$42357.69MPLXP
6$739,586,041,815$694,263,304,255.43$10,306$2,680.72+$739586.03MPLXP
7$12,120,492,876,395$11,329,135,811,652.31$12,820$4,101.38+$12120492.86MPLXP
8$186,486,946,005,072$173,518,018,627,329.40$17,673$6,826.70+$186486945.99MPLXP
9$2,694,646,789,868,656$2,495,105,757,643,229.00$27,543$12,591.86+$2694646789.84MPLXP
10$36,577,739,038,851,830$33,694,466,973,692,370.00$49,560$26,258.71+$36577739038.80MPLXP

PLXP vs PFE: Complete Analysis 2026

PLXPStock

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Full PLXP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PLXP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLXP vs SCHDPLXP vs JEPIPLXP vs OPLXP vs KOPLXP vs MAINPLXP vs JNJPLXP vs MRKPLXP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.